FLASHNEWS:

Category: Press Releases

Bitget Shines at Perú Blockchain Conference 2025

Bitget Shines at Perú Blockchain Conference 2025 LIMA, Peru, June 25, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange, and Web3 company has concluded a successful showing at the Perú Blockchain Conference 2025 as a Silver Sponsor, reinforcing its commitment to advancing crypto education and adoption across Latin America. Held from June 20 to 21 […]

Bitget Heads to Milan as Sponsor at ETHMilan 2025

Bitget Heads to Milan as Sponsor at ETHMilan 2025 VICTORIA, Seychelles, June 25, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, proudly joins ETHMilan 2025 as the official Viscoti Sponsor, aligned with its expansion strategy in Europe and beyond. Held on June 24 at the iconic Museo Nazionale Scienza e Tecnologia in […]

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]

Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin

Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studies DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced a strategic collaboration with Emery Pharma, a leading analytical and bioanalytical CRO providing testing services under current […]